Pioneering Complex Generics. Delivering Innovation.

For more than 25 years, our team at Iilco has successfully developed and launched over 200 generic products, many of which were first-to-market complex generics which had no competition for decades. Through strong partnerships with trusted contract manufacturers, we have maintained a reliable and efficient supply chain for these products. We take pride in our consistent ability to develop and bring to market complex, niche generics.

Iilco (UK) Ltd specializes in the research, development, and licensing of innovative new products for the human and veterinary markets. Our team focuses on identifying niche molecules across a wide range of therapeutic areas, leveraging our specialist expertise to successfully develop products that have traditionally been challenging to create. This has positioned us as leaders in the market. Additionally, we have significant experience in bringing licensed products to market that were previously used in an unlicensed capacity.

With a strong focus on innovation, the company is committed to developing value-added medicines that address unmet medical needs. Boasting a robust pipeline, Iilco (UK) Ltd is dedicated to delivering high-quality, cost-effective pharmaceutical solutions across a wide range of therapeutic areas.

Understanding the importance of supply continuity for prescribers, pharmacies, and patients, we have forged strong partnerships with contract manufacturers worldwide. This network provides us with deep expertise in manufacturing, batch release, logistics, and distribution. Combined with our strong relationships with leading wholesalers, we ensure that our products are delivered efficiently and effectively to our customers.